The Journal of
Clinical Psychiatry

Psychopharmacology

Letter to the Editor July 1, 2003

Fluoxetine Augmentation With Olanzapine for Treatment of Chronic Resistant Depression in an Elderly Patient: A Case Report

Mark B. Detweiler ; David B. Trinkle

J Clin Psychiatry 2003;64(7):851-852

Article Abstract

Letter to the Editor

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 86 • 2025 • Number 1

Read the Current Issue

Brief Report

Sex Differences in PTSD among US Military Veterans

Commentary

The Opioid Industry's Legacy: A Generation of Prescribed Suffering

Clinical and Practical Psychopharmacology

Cannabis Use in Pregnancy and ASD or ADHD in Offspring

Commentary

Evolving Care and Research Priorities in ADHD

Original Research

Treatments and Treatment Predictors in Patients With SUDs and ADHD

Systematic Review

Efficacy and Safety of Memantine for Children and Adults with ADHD

View current Issue

Letter to the Editor

Prazosin for Alcohol Use Disorder: A Clarification

September 21, 2021

Dr Sinha raises objections to statements made in a recent article on prazosin for alcohol use disorder.

Rajita Sinha

Letter to the Editor

Prazosin for Alcohol Use Disorder: Reply to Sinha

September 21, 2021

Dr Andrade responds to criticism of his recent article on prazosin for alcohol use disorder.

Chittaranjan Andrade

Letter to the Editor

Interactions With IL-6 Inhibitors and Agents for Opioid Use: Drs Mansuri and Colleagues Reply

February 18, 2021

In this letter to the editor, the authors reply to Kow and Hasan.

Zeeshan Mansuri , Bhumika Shah , Chintan Trivedi , et al

Fluoxetine Augmentation With Olanzapine for Treatment of Chronic Resistant Depression in an Elderly Patient: A Case Report

Read the Current Issue

Sex Differences in PTSD among US Military Veterans

The Opioid Industry's Legacy: A Generation of Prescribed Suffering

Cannabis Use in Pregnancy and ASD or ADHD in Offspring

Evolving Care and Research Priorities in ADHD

Treatments and Treatment Predictors in Patients With SUDs and ADHD

Efficacy and Safety of Memantine for Children and Adults with ADHD

ELSEWHERE:

FOLLOW US:

Fluoxetine Augmentation With Olanzapine for Treatment of Chronic Resistant Depression in an Elderly Patient: A Case Report

Read the Current Issue

Sex Differences in PTSD among US Military Veterans

The Opioid Industry's Legacy: A Generation of Prescribed Suffering

Cannabis Use in Pregnancy and ASD or ADHD in Offspring

Evolving Care and Research Priorities in ADHD

Treatments and Treatment Predictors in Patients With SUDs and ADHD

Efficacy and Safety of Memantine for Children and Adults with ADHD

Related Articles

Prazosin for Alcohol Use Disorder: A Clarification

Prazosin for Alcohol Use Disorder: Reply to Sinha

Interactions With IL-6 Inhibitors and Agents for Opioid Use: Drs Mansuri and Colleagues Reply

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles